Get started

Investing

Neat & Clean Rectangle Pattern Breakout seen in Top Cement StockHello Everyone, i hope you all will be doing good in your life and your trading as well. Today i have brought another stock which has given Near and Clean Rectangle pattern breakout. Stock name is UltraTech Cement and it is engaged in the manufacturing and sale of Cement and Cement related product primarily across globe. Okay guy's let's learn something very important about this pattern: Q:- What is Rectangle Pattern and How to Use Rectangle Chart Patterns to Trade Breakouts? Rahul:- A rectangle is a chart pattern formed when the price is bounded by parallel support and resistance levels. A rectangle exhibits a period of consolidation or indecision between buyers and sellers as they take turns throwing punches but neither has dominated. The price will “test” the support and resistance levels several times before eventually breaking out. From there, the price could trend in the direction of the breakout, whether it is to the upside or downside. we can clearly see Above in Ultratech chart that the pair was bounded by two key price levels which are parallel to one another. So, Traders, i hope you Guy's have learned today how to Trade Rectangle Pattern, but Mates We just have to wait until one of these levels breaks and go along for the ride! Remember , when you spot a rectangle: THINK OUTSIDE THE BOX! That's it. Market Leadership The company is the 3rd largest cement company in the world, excluding China. It is also the largest cement manufacturer in India with a 22% share of the grey cement capacity. Let's discuss some fundamentals - D/E is 0.17 - Interest Coverage ratio 10.73 is higher than last year's Interest Coverage Ratio 10.01 - D/E 0.17 has reduced as compared to last year's D/E 0.18 - ROCE is 15.42% - ROCE 15.42% has increased as compared to last year's ROCE 13.2% - ROE is 12.25% - ROE 15.42% has increased as compared to last year's ROE 13.2% - ROCE 15.42% is higher than 5 years ROCE average 14.02% - Operating Profit Margin (EBITDA Margin) is 18.29% - Operating Profit Margin (EBITDA Margin) 18.29% has improved as compared to last year's OPM 16.79% - NPM is 9.88% - Net Profit Margin (PAT Margin) 9.88% has improved as compared to last year's NPM 8.01% - Company has a negative Cash Conversion Days of -188.47 - Annual Sales has grown by 12.13% - Annual Profit has grown over by 38.33% - 3 Years Sales CAGR is 18.67% - Retail/Public have reduced their stakes by 0.32% in the latest quarter (14.4% to 14.08%) - Promoters + FIIs + DIIs hold 92.01% in the company Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's.
NSE:ULTRACEMCOLong
by TraderRahulPal
Hammer Candlestick Pattern Seen at bottom in Axis BankHello everyone i hope you all will be doing good in your life and your trading as well. Today i have brought axis bank analysis which is has formed Hammer candlestick pattern at bottom of Important support zone, Axis Bank Limited is a private sector bank. It has the third-largest network of branches among private sector banks and an international presence through branches in DIFC (Dubai) and Singapore along with representative offices in Abu Dhabi, Sharjah, Dhaka and Dubai and an offshore banking unit in GIFT City Market Leadership - 3rd largest private sector bank in India - 4th largest issuer of credit cards - 19.8% market share in FY24 Branch Network In FY24, Bank added 475 branches (125 in Q4FY24) to its network. At present, it has a total of 5377 branches, 16,026 ATMs and Cash recyclers. The region-wise breakup of branches is as follows: Metro - 31% Semi-urban - 29% Urban - 23% Rural - 17% Loan Book Retail loans account for 60% of bank's loan book and corporate 29% & SME loans 11%. Retail Book Home loans account for 28% of retail book, followed by rural loans (16%), LAP(11%), Auto loans(10%), personal loans(12%) , small business banking (10%), credit cards (7%), Comm Equipment (2%) & others (4%) Market Share FY24 - Bank has 5.5% market share in assets, 5% in deposits & 5.9% in advances. - 14% in credit cards circulation in India. - 5.2% market share in personal loan. - 4% RTGS, 30% NEFT, 38.9% IMPS Market share (by volume),20% Market share in BBPS. - 11.4% Foreign LC Market Share. - 8.4% market share of MSME credit. Fundamental (Ratio) Analysis - P/E ratio is 12.69 - P/E ratio is 12.69 which is lower than it's 5 years Average P/E 28.22 - D/E 1.46 has reduced as compared to last year's D/E 1.59 - ROCE is 14.16% - ROCE 14.16% has increased as compared to last year's ROCE 9.26% - ROE is 18.51% - ROE 14.16% has increased as compared to last year's ROE 9.26% - ROCE 14.16% is higher than 5 years ROCE average 9.19% - ROE 18.51% is higher than 5 years ROE average 10.03% - PEG ratio is 0.61 - Operating Profit Margin (EBITDA Margin) 8.82% has improved as compared to last year's OPM - 0.31% - NPM is 23.4% - Net Profit Margin (PAT Margin) 23.4% has improved as compared to last year's NPM 12.37% - Annual Sales has grown by 28.94% - Annual Profit has grown over by 143.91% - 3 Years Sales CAGR is 20.96% - 3 Years Profit CAGR is 142.38% - Quarterly Sales has grown over by 15.26% YoY - Quarterly Profit has grown over by 19.16% YoY - Quarterly Profit has grown over by 14.87% QoQ - DII have increased their stakes by 1.72% in the latest quarter (29.4% to 31.12%) - Retail/Public have reduced their stakes by 0.91% in last 3 years - Promoters + FIIs + DIIs hold 91.18% in the company Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's.
NSE:AXISBANKLong
by TraderRahulPal
Invest in ZENTEC: Pioneering Next-Gen Defence Solutions◉ Abstract Zen Technologies Ltd is set for strong growth in the Indian defense market. The market is expected to rise from USD 17.40 billion in 2024 to USD 23.05 billion by 2029. The company focuses on advanced training and counter-drone solutions, and is benefiting from government initiatives of promoting indigenous production under the “Make in India” project. Moreover, Indian Govt. plans to double defense spending by FY30. A recent partnership with AVT Simulation will help Zen expand in the U.S. market. With a solid order book of ₹3,500 Crores and a revenue goal of ₹900 Crores for FY2025, Zen is investing heavily in research and development. Although its high PE ratio may suggest it’s overvalued, the company’s strong finances and growth plans indicate good potential for investors. Read full analysis here: ◉ Introduction The Indian Defence Market is expected to experience significant growth in the coming years. According to a recent report, the market size is estimated to be USD 17.40 billion in 2024 and is projected to reach USD 23.05 billion by 2029. ◉ Growth Drivers ● Government Initiatives: The Indian government is heavily promoting indigenous production through initiatives like "Make in India," which aims to reduce dependency on imports and bolster local manufacturing capabilities. ● Increased Defence Spending: India's defence budget is expected to double between FY24 and FY30, with significant allocations for new weapons procurement and R&D. For FY 2023-2024, the budget for new weapons procurement is set at USD 19.64 billion, along with USD 2.79 billion for research and development. ● Geopolitical Tensions: Ongoing border disputes with neighbouring countries such as China and Pakistan necessitate increased military spending and modernization efforts. ● Export Opportunities: Indian defence exports have surged significantly, rising from USD 200 million in FY17 to USD 2.6 billion in FY24, with expectations to reach USD 7 billion by FY30. The government's focus on enhancing export relationships with countries like Italy, Egypt, and Saudi Arabia further supports this growth. This in-depth report shines the spotlight on Zen Technologies , a mid-cap defence company that has carved a niche for itself in the Indian defence landscape. With a keen focus on pioneering training solutions and cutting-edge counter-drone technologies, Zen Technologies has emerged as a significant player in the industry. ◉ Investment Advice 💡 Buy Zen Technologies NSE:ZENTEC ● Buy Range - 2000 - 2050 ● 1st Target - 2500 - 2600 ● Potential Return - 25% - 30% ● 2nd Target - 2800 ● Potential Return - 40% ● Approx Holding Period - 12-14 months ◉ Company Overview Zen Technologies Limited, incorporated in 1996, specializes in designing, developing, and manufacturing cutting-edge combat training solutions and Counter-drone solutions for defence and security forces. The company is committed to the indigenization of technologies that benefit the Indian armed forces, state police forces, and paramilitary forces, providing them with innovative training solutions to enhance their combat readiness. With its headquarters in Hyderabad, India, Zen Technologies Limited has a significant global presence, with offices in India, UAE, and the USA. This widespread presence enables the company to effectively support its clients and partners worldwide. ◉ Market Capitalization - ₹18,858 Cr. ◉ Expansion into U.S. Market ➖ Zen Technologies recently signed a Memorandum of Understanding (MoU) with AVT Simulation to enhance its presence in the U.S. defence sector. This partnership aims to leverage AVT’s expertise in simulation technologies to introduce Zen's products to U.S. defence agencies. ◉ Revenue Projections for FY2025 ➖ Despite a strong start to the fiscal year, with revenues reaching ₹500 Crores in the first half, Zen Technologies' management has set a cautious revenue target of ₹900 Crores for FY2025. ◉ Expansion Plans ➖ Zen Technologies aims to expand into the Navy and Air Force segments through organic growth and acquisitions. ➖ The company plans to acquire Indian and overseas businesses, with deal sizes between ₹100-₹300 Crores. ◉ Investment in R&D ➖ Zen Technologies is investing heavily in research and development (R&D) to drive innovation and stay ahead of the curve. ➖ The company is currently developing new products that are reportedly two generations more advanced than those showcased in 2021. This focus on R&D underscores Zen Technologies' dedication to delivering cutting-edge solutions that meet the evolving needs of its customers. ◉ Order Book Status ➖ A substantial order pipeline of ₹3,500 Crores is in place, with ₹1,200 Crores expected to be executed in the next financial year. ➖ Order inflow is forecasted to pick up significantly towards the end of Q3 and into Q4 of FY2025, positioning for continued growth and success. ◉ Margin Expectations ➖ Management targets 35% EBITDA margin and 25% PAT margin, despite current gross margin pressures due to product and geographical mix changes. ◉ Revenue & Profit Analysis ● Year-on-year ➖ The company's FY24 performance was marked by impressive growth, with sales reaching ₹440 crore, representing a 100% year-over-year increase. ➖ EBITDA also surged significantly, rising to ₹181 crore from ₹73 crore in FY23. ➖ Notably, the company achieved a substantial EBITDA margin of 41%, highlighting its operational efficiency and profitability. ● Quarter-on-quarter ➖ The company's recent quarter sales stood at ₹242 crore, a decline from the previous quarter, but a substantial increase from ₹66 crore in the same quarter last year. ➖ EBITDA dropped to ₹80 crore from ₹111 crore in the previous quarter. ◉ Valuation ● P/E Ratio ➖ The stock's current price-to-earnings (PE) ratio of 93.1 appears overstretched compared to its industry average PE of 51.6. ➖ Furthermore, relative to its 1-year median PE of 76.5, the stock seems overvalued, suggesting potential downside risks. ● PEG Ratio ➖ When we look at the PEG ratio of just 1.64, the stocks looks fairly valued relative to its anticipated earnings growth. ◉ Cash Flow Analysis ➖ The company's operating cash flow experienced a substantial decline in FY24, plummeting to ₹13 crore from a robust ₹116 crore in FY23. ◉ Debt Analysis ➖ With a debt-to-equity ratio of just 0.04, the company enjoys a virtually debt-free status, underscoring its robust financial health and providing a solid foundation for future expansion. ◉ Top Shareholders ➖ In the September quarter, promoters reduced their stake to 51.26% from 55.07% in the previous quarter. ➖ Foreign Institutional Investors (FIIs) have significantly raised their holdings to 5.72%. ➖ Domestic Institutional Investors (DIIs) also increased their stakes, now at 8.05%, up from 3.37% in June. ➖ Conversely, retail investors sold shares, decreasing their holdings to 34.5% from 37.94% in June 2024. ◉ Mutual Fund Exposure ➖ Institutional holdings in Zen Technologies skyrocketed by 550% to 42 lakh shares in October 2024, with 23 funds taking a significant stake, up from 6.4 lakh shares in July. ◉ Bulk Deal Alert ➖ On December 3, 2024, Motilal Oswal Mutual Fund acquired over 11 lakh shares of Zen Technologies through a bulk deal. ◉ Technical Standings ➖ The monthly chart clearly illustrates a strong upward trend in the stock, marked by a series of higher highs and higher lows. ➖ The daily chart also presents a bullish scenario, with the formation of an Ascending Triangle pattern. ➖ A fresh breakout from this pattern is likely to propel the stock to new highs. ◉ Conclusion Following a comprehensive analysis of fundamental and technical indicators, we firmly believe that Zen Technologies is well-positioned for robust growth, underpinned by its innovative solutions and strong research and development capabilities. The company's strategic expansion plans into key markets, particularly the United States, are expected to unlock vast opportunities, driving significant growth in revenue and profitability. This, in turn, is likely to have a positive impact on the company's top-line and bottom-line performance, as well as its share price.
NSE:ZENTECLong
by GoodluckCapital
Kalyan Jewellers. Aiming for another up move?#Tradeideas. #klayanjewellers. After a strong stage 2 uptrend, the stock is pulling back forming a Flag and pole. Trying to breakout of it. 🟢Trdaing right at 50 DMA. Formed a bullish Marabozu at 50 DMA. 🟢Bullish sentiments of Jewellery stocks around marriage season. 🔴 Q2 results around the corner. If the results are not as per the market then good chance for hitting SL. 🔴Overall bearish sentiments in the market. Watch this counter closely. Risk is in the range of 10-11%. If ATH is broken with good volume and a good candle very good chance for further upmove. Do your due diligence.
NSE:KALYANKJILLong
by sagartharayil
Thangamayil shining: The strong financials caused a price surge!Company Overview Thangamayil Jewellery Limited (TMJL) is a rapidly growing company in India with a chain of retail jewellery stores in Tamil Nadu. They specialize in selling Gold, Silver, Diamonds, and Platinum, with gold being the main source of income. The majority of their ornaments are purchased from dealers in states like Andhra Pradesh, Gujarat, Kerala, and West Bengal for sale in their stores. Established in 1947, Thangamayil is headquartered in Madurai, India. Market Capitalization ● Current Market Cap - ₹ 5,128 Cr. ● Market Cap 3-years back - ₹ 802 Cr. ● The figures indicate that the company has increased over six times in the past three years, which is truly remarkable. Revenue & Profit Growth ● In the last three years, this stock has demonstrated an impressive compounded annual growth rate of 28% in its sales figures. ● Meanwhile, the total profit growth during this period has been a modest 12%. ● The company has successfully maintained a operating profit margin of 6%, which has risen from 4% in FY24. ● For the fiscal year 2024, the earnings per share have seen a remarkable increase, soaring from 29.10 in fiscal year 2023 to 44.91. Increasing Product Demand ● Inventory Turnover Ratio ➖ This ratio typically assists in determining whether the growth in sales is primarily due to rising product prices or if it is also influenced by increased demand for the product. ➖ Current Inventory Turnover - 3.14 ➖ Inventory Turnover 3 years ago - 2.63 ➖ These figures indicate that product demand has risen over the past three years. Valuation ● P/E Ratio The company's present price-to-earnings (PE) ratio stands at 42.3, significantly higher than its 1-year median PE of 31. When we look at the industry average PE of 31.6, it indicates that the stock might be considered somewhat overvalued at this time. ● PEG Ratio The company has a PEG ratio of 1.3, indicating that its current P/E ratio is valid. ● Intrinsic Value ➖ Thangamayil Jewellery is currently trading at ₹1870, which is nearly 2.5 times its intrinsic value of ₹764, indicating that the stock is overvalued at this moment. ➖ When we compare Thangamayil to its competitors, such as Titan and Kalyan Jewellers, some interesting insights emerge. Titan's current market price (CMP) stands at ₹3560, which is nearly 5.5 times its intrinsic value of ₹652. Meanwhile, Kalyan Jewellers has a CMP of ₹545, approximately 4.7 times its intrinsic value of ₹115. ➖ These numbers don't necessarily indicate that Titan and Kalyan Jewellers are overvalued; rather, they suggest that Thangamayil could be an attractive investment choice. Debt Analysis ● Debt to Equity Ratio ➖ The company carries a debt of approximately ₹532 Cr., resulting in a debt-to-equity ratio of 1.08. ➖ When discussing debt, it's important to note that for a small-cap company, this isn't necessarily a major concern. The key factor to consider is whether the company can consistently meet its loan interest payments. ➖ To assess this, we should examine the interest coverage ratio. ● Interest Coverage Ratio With an interest coverage ratio of 5.62, it’s evident that the company is well-equipped to manage its loan interest payments regularly. Cash Flow Analysis ● Operating cash flow has seen a remarkable surge, soaring to 330 crore from just 10 crore in FY23. ● The CFO/PAT ratio is currently at 0.74 of the five-year average, indicating that the company is quite proficient at converting its profits into cash. Shareholding Pattern ● The promoters have maintained their 67.33% stake for the last three quarters. ● Foreign Institutional Investors (FIIs) have been steadily raising their stakes since June 2023, now holding 1.08%. ● Domestic Institutional Investors (DIIs) have also grown their stakes to 12.08% in June 2024, up from 11.46% in June 2023. ● At the same time, retail investors have been consistently selling their shares over the past few quarters. Mutual Fund Holding ● Notable small-cap funds such as SBI Small Cap Fund and DSP Small Cap Fund have made substantial investments in this stock, representing 0.63% and 1.55% of their total assets under management, respectively. ● Additionally, ICICI Prudential Exports and Services Fund has recently added (in July 2024) its position in this stock, accounting for approximately 1.11% of its overall portfolio value. Technical Aspects ● From a technical standpoint, this stock appear to be currently overextended. Any pullbacks could provide a valuable opportunity to take positions. ● Stock Volume & Delivery surged by 3.4 times & 3.2 times respectively vis-a-vis their 5 day average with a 5.48% move in price. Conclusion While the company primarily functions in Tamil Nadu, it's fascinating to note that this state accounts for the largest portion (40%) of India's overall gold consumption. Furthermore, the company is gearing up to make its mark in the Chennai market by launching a flagship store along with 3-4 satellite locations. Given the increasing demand for gold jewelry, we anticipate that Thangamayil Jewellery will thrive in the industry in the years ahead.
NSE:THANGAMAYLLong
by GoodluckCapital
1
A Healthcare Face-Off: Apollo vs. Narayana◉ Abstract India's hospital industry is growing rapidly, valued at ₹8.35 lakh cr. ($98.98 B) in 2023, with a projected CAGR of 5.8-8.0% from 2024 to 2032. Apollo Hospitals and Narayana Hrudayalaya are two leading players, with Apollo being the largest private hospital network and Narayana Hrudayalaya known for cost-effective cardiac care. Narayana Hrudayalaya appears undervalued with a P/E ratio of 33.5 and more profitable (ROCE: 27%), making it an attractive investment option. Apollo Hospitals seems overvalued with a P/E ratio of 83.4 but remains viable for strategic entry points. Both companies are poised for growth driven by increasing healthcare demands and infrastructure expansion. Read full analysis here........ ◉ Introduction The hospital industry in India is experiencing significant growth, with the market valued at approximately ₹8.35 lakh cr. ($98.98 B) in 2023. Projections indicate a robust compound annual growth rate (CAGR) of 5.8% to 8.0% from 2024 to 2032, potentially reaching between 13.87 lakh cr. and 16.33 lakh cr. ($164.4 B - $193.6 B) by 2032, depending on various market analyses. ◉ Growth Drivers of the Indian Hospital Industry ● Increased Healthcare Expenditure: ➖ Rising public and private spending on healthcare, with government health expenditure aiming for 2.5% of GDP by 2025. ➖ Expanding middle class with higher disposable incomes and greater access to health insurance. ● Technological Advancements: ➖ Adoption of healthcare technologies such as telemedicine and robotic automation, improving service delivery. ➖ National Digital Health Blueprint promoting innovations in e-health. ● Policy Support and Foreign Investment: ➖ Favourable government policies allowing 100% FDI in healthcare, attracting significant investments. ➖ Public-private partnerships enhancing healthcare access, especially in underserved areas. ● Demand for Specialized Services: ➖ Increasing incidence of lifestyle diseases driving demand for specialized healthcare. ➖ Growth in medical tourism as India becomes a preferred destination for cost-effective treatments. These factors are collectively propelling the growth of the hospital industry in India, positioning it for a promising future. ◉ Key players in the Indian hospital sector 1. Apollo Hospitals leads the sector with a market capitalization of approximately ₹98,646 Cr, establishing itself as the largest private hospital network in India. 2. Max Healthcare closely follows, boasting a market capitalization of around ₹97,820 Cr. 3. Fortis Healthcare is another key participant in the market, with a market capitalization of ₹48,249 Cr. 4. Global Health also ranks among the premier healthcare institutions, holding a market capitalization of ₹28,786 Cr. 5. Narayana Hrudayalaya is recognized for its cost-effective cardiac care services and maintains a notable market share with a market capitalization of ₹26,086 Cr. In this report, we will conduct an in-depth analysis and comparison between two of India's leading healthcare providers, Apollo Hospitals and Narayana Hrudayalaya. This comprehensive evaluation will assess their technical and fundamental aspects, ◉ Company Overviews ● Apollo Hospital NSE:APOLLOHOSP Apollo Hospitals was founded in 1983 by Dr. Prathap C Reddy, a visionary in the evolution of modern healthcare in India. As the first corporate hospital in the country, Apollo Hospitals is celebrated for leading the charge in the private healthcare transformation. Today, Apollo Hospitals stands as Asia's leading integrated healthcare services provider, boasting a strong footprint throughout the healthcare landscape. This includes a diverse range of services such as hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. ● Narayana Hrudalaya NSE:NH Narayana Hrudayalaya Limited is involved in providing medical and healthcare services both in India and abroad. It functions through two main divisions: Medical and Healthcare Related Services, and Others. The organization is responsible for acquiring, owning, and managing a variety of healthcare facilities, including hospitals, clinics, health centres, diagnostic centres, and nursing homes, among other related operations. Its range of services encompasses cardiology, cardiac surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, pediatrics, neonatology, gastroenterology, and oncology. Additionally, the company is active in the health insurance sector. Established in 2000, its headquarters is located in Bengaluru, India. ◉ Technical Analysis ● Apollo Hospitals ➖ The stock faced a significant obstacle near the 5,800 level, resulted in a steep drop. ➖ It later found support around 3,500 and rebounded. ➖ Following an extended period of consolidation, the price developed a Rounding Bottom pattern. ➖ A breakout ensued, leading to a price increase, but it encountered resistance close to 6,800, which triggered a pullback to the breakout point. ➖ Following a successful retest, the price surged past the previous high, reaching a new peak at 7,545. ➖ However, due to prevailing negative market sentiments, the price has since retraced and is currently trading just above its immediate support zone. ● Narayana Hrudalaya ➖ The stock price is overall in an uptrend. ➖ After reaching an all-time high close to the 1,445 level, the price experienced a decline and has since entered a consolidation phase. ➖ A Symmetrical Triangle pattern has formed on the chart. ➖ We expect an upward breakout from this pattern, which could lead to a significant price rally. ◉ Relative Strength ➖ The chart reveals that both Apollo and Narayana Hrudayalaya have underperformed the Nifty Healthcare index. Although Apollo has given a descent 31% return, Narayana lagged significantly, yielding a modest 17% return. In contrast, the Nifty Healthcare index delivered an impressive 41% return. ◉ Service Wise Revenue Breakdown ● Apollo Hospitals The company operates through three primary segments, each contributing significantly to its revenue. ➖ Healthcare services account for approximately 52% of total revenue, forming the largest share. ➖ The retail pharmacy business generates nearly 41% of total sales, while the retail health and diagnostics segment contributes the remaining 7%. ● Narayana Hrudalaya ➖ The company operates exclusively in the healthcare services sector, deriving all its revenue from this single segment. ◉ Revenue & Profit Analysis ● Apollo Hospitals Year-over-Year ➖ The company's fiscal year 2024 performance was marked by strong growth, with revenue reaching ₹19,059 crore, a 15% increase from ₹16,612 crore in FY23. ➖ EBITDA surged to ₹2,394 crore, up from ₹2,065 crore in FY23, while the EBITDA margin improved to 13% from 12%. Quarter-over-Quarter ➖ In the latest quarter ending September 2024, the company achieved its highest-ever sales of ₹5,589 crore, significantly up from ₹5,086 crore in June 2024. This quarter-on-quarter growth has been consistent since March 2022. ➖ EBITDA for the quarter was an impressive ₹816 crore, a 21% increase from ₹675 crore in June 2024. ➖ Diluted EPS (LTM) rose substantially to ₹83.31 from ₹72.13 in June 2024. ● Narayana Hrudalaya Year-over-Year ➖ In FY24, our company achieved remarkable sales growth, surging 11% to ₹5,018 crore from ₹4,525 crore in FY23. ➖ EBITDA soared to ₹1,173 crore, up from ₹987 crore in the same period, with an impressive EBITDA margin of 23%. Quarter-over-Quarter ➖ Our quarterly sales reached an all-time high of ₹1,400 crore in September, representing a 4% increase from ₹1,341 crore in June. ➖ Although EBITDA growth was modest, it still improved to ₹308 crore in September from ₹304 crore in June 2024. ➖ However, Diluted EPS experienced a decline, dropping to ₹38.85 from ₹39.72. ◉ Valuation ● P/E Ratio ➖ Apollo Hospitals' current P/E ratio stands at 83.4, down from its 1-year median of 107.7. However, this remains significantly above the industry average of 56.9, indicating overvaluation. ➖ In contrast, Narayana Hrudalaya's P/E ratio of 33.5 is slightly above its 1-year median of 32.8 and substantially below the industry average, suggesting undervaluation. ● P/B Ratio ➖ Apollo's P/B ratio of 13.15 indicates considerable overvaluation compared to the industry average of 7.18. ➖ Narayana Hrudalaya's P/B ratio of 8.14 also suggests overvaluation, albeit to a lesser extent. ● PEG Ratio ➖ Narayana's PEG ratio of 0.49 positions it as an attractive investment opportunity, especially when compared to Apollo's considerably higher PEG of 2.43. ◉ Profitability Analysis ➖ Apollo Hospitals ROCE - 15% in FY24 ➖ Narayana Hrudalaya ROCE - 27% in FY24 The significant difference in ROCE between the two healthcare giants underscores Narayana Hrudalaya's superior profitability. Narayana's impressive ROCE of 27% demonstrates its ability to efficiently utilize its total capital, comprising both equity and debt, to generate substantially higher returns. ◉ Cash Flow Analysis ➖ Apollo Hospitals has demonstrated impressive growth in its operating cash flow, surging 39% to ₹1,920 crore in FY24 from ₹1,377 crore in FY23. This robust growth underscores the company's efficiency in converting profits into cash, highlighting its strong financial health and liquidity position. ➖ In contrast, Narayana Hrudalaya has shown sluggishness in turning profits into cash, with its operating cash flow declining 2% to ₹1,067 crore in FY24 from ₹1,085 crore in FY23. ◉ Debt Analysis ➖ Apollo Hospitals' debt stands at ₹7,371 crore, resulting in a debt-to-equity ratio of 0.98, which, although relatively high, is not alarming. However, the company's low interest coverage ratio of 4.69 raises concerns about its ability to service its debt. This vulnerability may complicate repayment of borrowed loans, potentially straining Apollo's financial stability. ➖ In contrast, Narayana Hrudalaya's debt of ₹1,703 crore and debt-to-equity ratio of 0.53 indicate robust financial health. Furthermore, its impressive interest coverage ratio of 8.34 suggests the company is well-positioned to manage its debt obligations, ensuring greater financial flexibility and stability. ◉ Shareholding Pattern ● Apollo Hospitals ➖ In the September quarter, Foreign Institutional Investors (FIIs) increased their stake in Apollo Hospitals to 45.37%, up from the previous quarter. ➖ Conversely, Domestic Institutional Investors (DIIs) reduced their holdings to 19.94%, a significant decrease from 24.77% in the last quarter. ● Narayana Hrudalaya ➖ In contrast, Narayana Hrudalaya witnessed a decline in institutional investor holdings. FIIs reduced their stake to 9.69%, down from 10% in the previous quarter. ➖ Domestic Institutional Investors (DIIs) also decreased their holdings to 7.9%, down from 8.22% in the June quarter. ◉ Conclusion Following a comprehensive analysis of both technical and fundamental aspects, we conclude that Narayana Hrudalaya appears to be favorably positioned from a valuation perspective, presenting an attractive investment opportunity. However, this does not diminish Apollo Hospitals' potential. Although the stock currently appears overvalued, investors can consider accumulating shares during dips, making it a viable option for those seeking strategic entry points. The healthcare sector's promising growth trajectory, fueled by rising healthcare demands and infrastructure expansion, positions both companies for potentially excellent returns in the near future.
NSE:APOLLOHOSPLong
by GoodluckCapital
2
KPITTECH at make or break level.#kpittech - At a crucial Support region. - Fell out of the rising wedge with huge volume. -Fell out of a base with huge volume. Implying a potential stage 4 - Support zone tested several times. - Stock used to trend smoothly taking support at 200 DMA. Which is broken now. - 1300 levels are not held then the possibility of testing 1K region. Looking for reversal is now not wise. The market is sell on the rise. Any long-term investors itching to buy the dip can consider adding a very limited quantity at 1300 region. As of now looks very weak. It would be great if we get it at 1K level. I am not a fan of short selling but if anyone is good at that then keep this on radar. This is just a view please do not take a decision without consulting your financial advisors. Chart shared is just for educational purposes.
NSE:KPITTECH
by sagartharayil
Tatamotors. Go long to appease the bottom fisher in you.#Tradeideas #tatamotors : Just to appease the bottom fisher inside you one can try going long at this juncture. Tata Motors at crucial support. Forming a green candle at that region, could be a potential reversal. Entry is possible at this stage with a small quantity. More like a probe quantity. Do not risk more than 5% in this trade in my opinion. If we are catching the reversal then the reward is high. That is the sole reason for sharing this idea. Remember, these could go against the trade: 🔴Bad Q2 results. 🔴Weak Market sentiments. 🔴Need more confirmation of a reversal. 🔴Way below all Key DMAs. 🔴Bearish Structure. If you weigh in everything this is a low-probability trade. So risk less. This is just a view and not a recommendation.
NSE:TATAMOTORSLong
by sagartharayil
Muhurat Day Investment Pick for long Term (ABSLAMC)Hello everyone, i wish you all Happy Deepawali and new sanvat Year, i hope new year brings you good wealth and good health. Today i am publishing a stock on special day (MUHURAT TRADING DAY), It is a long term investment idea from my side, i am also holding this stock and today again i have added in my portfolio. Stock is really good having good management and right now stock has given Rounding bottom pattern breakout with huge volume. All the levels i already have written on chart. I am expecting huge rally ahead in it, think for long term like 10 years plus and you will get huge returns. About:- Incorporated in 1994, Aditya Birla Sun Life AMC is set up as a joint venture between Aditya Birla Capital Ltd and Sun Life AMC. The Co. offers Mutual Fund services, Portfolio Management services, offshore and real estate offerings. Key Points:- India’s Leading AMC ABSBL is one of the largest non-bank affiliated AMC in India managing AUM of ₹6002 bn under its suite of mutual funds, portfolio management services, offshore and real estate offerings Market Cap ₹ 23,138 Cr. Current Price ₹ 802 High / Low ₹ 804 / 436 Stock P/E 25.8 Book Value ₹ 113 Dividend Yield 1.67 % ROCE 34.9 % ROE 27.4 % Face Value ₹ 5.00 Industry PE 22.6 Debt ₹ 75.0 Cr. EPS ₹ 31.1 Promoter holding 75.0 % Intrinsic Value ₹ 382 Pledged percentage 0.00 % EVEBITDA 19.0 Change in Prom Hold -0.05 % Profit Var 5Yrs 11.8 % Sales growth 5Years 3.05 % Return over 5years % Debt to equity 0.02 Net profit ₹ 896 Cr. ROE 5Yr 30.9 % Profit growth 34.8 % Earnings yield 5.14 % PEG Ratio 2.19 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's.
NSE:ABSLAMCLong
by TraderRahulPal
2
After falling 25% Nifty50 stock is giving good entry to go long Hello Everyone, i hope you all will be doing good in your trading and your life as well. Today i have brought Bajaj-Auto stock which has fallen 25% from all time high and now trading at importance support zone, There is higher probability for reversal from these levels. It is giving good entry for short term to long term traders and investors. Bajaj Auto, the flagship company of Bajaj Group, is a two-wheeler and three-wheeler manufacturing company that exports to 79 countries across several countries in Latin America, Southeast Asia, and many more. Its headquarter is in Pune, India. It has acquired 48% of the KTM Brand which manufactures sports and super sports two-wheelers, which was 14% in 2007 when the company first acquired KTM. Market Leadership:- The company is the 2nd-largest player in the domestic motorcycle segment in terms of volume. It is the largest 3W producer in the world and the largest exporter of 2W and 3W from India. Manufacturing Capacity:- The company has five manufacturing plants, of which two are in Chakan and one each in Waluj, Akurdi, and Pantnagar, with a total installed capacity of 7.1 million units per annum. Expansion:- In FY24, the company set up a new plant in Brazil with an initial capacity of 20k units/ month that commenced commercial production on Jun 24. It will incur capex of Rs. 600 Cr -Rs. 700 Cr in FY25-FY26, largely towards maintenance activities. Vehicle Financing:- Its wholly-owned captive financing company Bajaj Auto Credit Ltd. commenced business in Maharashtra and Goa on 1st Jan 24 and expanded to Kerala, Karnataka, Tamil Nadu, Andhra Pradesh, Telangana, Rajasthan, and Gujarat. It plans to cover all the balance states by FY25. On Apr 24, the board approved additional investment in BACL of Rs. 2250 Cr, in addition to the existing Rs. 600 Cr approved earlier, to fund its expansion plans. Market Cap ₹ 2,72,363 Cr. Current Price ₹ 9,753 High / Low ₹ 12,774 / 5,285 Stock P/E 36.9 Book Value ₹ 1,109 Dividend Yield 0.80 % ROCE 33.5 % ROE 26.5 % Face Value ₹ 10.0 Industry PE 64.6 Debt ₹ 5,245 Cr. EPS ₹ 263 Promoter holding 55.0 % Intrinsic Value ₹ 3,891 Pledged percentage 0.01 % EVEBITDA 25.8 Change in Prom Hold -0.01 % Profit Var 5Yrs 10.7 % Sales growth 5Years 8.13 % Return over 5years 25.2 % Debt to equity 0.17 Net profit ₹ 7,371 Cr. ROE 5Yr 21.8 % Profit growth 7.74 % Earnings yield 3.64 % PEG Ratio 3.46 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:BAJAJ_AUTOLong
by TraderRahulPal
2
Dr Reddy is Ready to fly in blue sky, Short term Trading Idea .I hope you all will be doing good in your life and your trading as well. I have brought a stock which has formed a pull back pattern and taken support at previous breakout zone. Stock name is Dr. Reddy's Laboratories Ltd and it is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Stock is good for short term trading idea as it has taken support in the previous breakout zone. Stock is good for long term investing as well. This can be best SIP stock to invest and get handsome returns in future. Market Cap ₹ 1,09,439 Cr. Current Price ₹ 1,312 High / Low ₹ 1,421 / 1,041 Stock P/E 19.7 Book Value ₹ 339 Dividend Yield 0.61 % ROCE 26.5 % ROE 21.4 % Face Value ₹ 1.00 Industry PE 34.5 Debt ₹ 2,002 Cr. EPS ₹ 66.7 Promoter holding 26.6 % Intrinsic Value ₹ 1,033 Pledged percentage 0.00 % EVEBITDA 12.3 Change in Prom Hold -0.01 % Profit Var 5Yrs 24.4 % Sales growth 5Years 12.6 % Return over 5years 18.9 % Debt to equity 0.07 Net profit ₹ 5,565 Cr. ROE 5Yr 16.7 % Profit growth 17.8 % Earnings yield 6.77 % PEG Ratio 0.81 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:DRREDDYLong
by TraderRahulPal
7